A potential mechanism linking VEGF inhibitors to cerebral infarction is the inhibition of VEGF receptors (VEGFR) signaling, leading to increased vasoconstriction through reduced nitric oxide and prostacyclin production, which can cause hypertension [4,29,30]. Here, KDR is linked to cerebral infarction.